Why list on ASX?

Gain access to capital in the world’s fastest growing region, with dedicated support from a top 10 global exchange

Capital and liquidity

The world’s 5th largest pension pool, set to grow to $9 trillion by early 2040s
Enhanced liquidity; $8 billion in trading turnover on a daily basis
Average of $9 billion in IPO capital raised per annum 2017-21

Global reach

Top 10 global exchange for capital raising
40% international institutional investors, providing a gateway to global capital
Potential to gain entry into a globally recognised index at a relatively early stage

Support for early stage and mature companies

Long history of funding and listing early stage growth companies
A dedicated support program to help you reach out to investors

A globally recognised exchange

Robust regulatory environment with a main board listing
Over 2,000 listed companies across multiple sectors and geographies
A leader in trading infrastructure and technological innovation

Case studies of recently listed companies

ASX:FCL

Irish Fintech company Fineos’ listing provided expansion capital to increase sales and product delivery and allowed their existing shareholders partial liquidity.

Market cap at listing	$661 million
Capital raised	$211 million

ASX:JDO

Judo Bank’s listing enabled financial flexibility to support its regulatory capital requirements and provided liquidity to their existing shareholders.

Market cap at listing	$2.3 billion
Capital raised	$653 million

ASX:SQ2

US Fintech company Block’s secondary listing on ASX, following their acquisition of ASX listed Afterpay, enhanced liquidity and broadened their shareholder base.

Market cap at listing	$81.1 billion
Capital raised	Afterpay consideration

ASX:SDR

Siteminder’s listing provided funding to support its growth strategy and allowed their existing shareholders partial liquidity.

Market cap at listing	$1.4 billion
Capital raised	$627 million

Get to know recently listed companies

Australian Clinical Labs (ASX: ACL)

Giri Tenneti speaks to Australian Clinical Labs CEO, Melinda McGrath.

Airtasker (ASX:ART)

Giri Tenneti speaks to Airtasker Limited founder and CEO, Tim Fung.

Aroa Biosurgery (ASX:ARX)

Blair Harrison speaks to Brian Ward, CEO, Executive Director & Founder of NZ-based Aroa Biosurgery.

Why international companies should consider the ASX

Australia’s large, fast-growing pension pool, main board listing and earlier entry to globally recognised indices makes ASX the exchange of choice for international companies. More than 270 international companies are currently listed on ASX.